News & Events
October 29, 2020
WEBINAR – COVID-19: Risk Assessment and Mitigation Strategies for the Collection of PRO Data through Clinical Sites – Lessons Learned
Join Critical Path Institute’s Electronic Patient-Reported Outcome (ePRO) Consortium and Patient-Reported Outcome (PRO) Consortium for a free 1-hour webinar to discuss how the collection of ePRO data in clinical trials has been impacted by COVID-19. Hear from sponsors and eCOA providers as they discuss lessons learned from managing clinical trials that originally planned for in-person collection of ePRO data through clinical sites.
October 28, 2020 - October 29, 2020
October 28-29 | International Neonatal Consortium 2020 Virtual Workshop
This two-day virtual workshop, hosted in collaboration with EMA, will bring together hundreds of INC consortia members and collaborators from across the world, ranging from academic and industry researchers, regulators, parent and nursing representatives, to discuss some of the most important topics in the field of neonatology research, including:
Racial and health equity in neonatal clinical trials
Clinical trial design and execution
Treatments administered to pregnant women for the benefit of neonates
Using real-world-data to generate real-world-evidence in neonatology
Each topic will feature presentations by subject matter experts, followed by a panel discussion and Q&A session.
Register now: https://bit.ly/INC2020Workshop
October 27, 2020 - October 27, 2020
Critical Path for Alzheimer’s Disease 2020 Annual Meeting and Regulatory Science Workshop – Virtual
October 27, 2020 | 9:30 a.m. – 1 p.m. (US Eastern Time)
The Critical Path for Alzheimer’s Disease (CPAD) is a Critical Path Institute public-private partnership aimed at generating actionable solutions and knowledge towards advancing drug development across the AD continuum.
Access the full agenda here. To register, visit: http://www.cvent.com/events/cpad-2020-virtual-annual-meeting-regulatory-science-workshop/event-summary-10373ef7c3d942edb1f0156657cd4063.aspx
October 19, 2020 - October 19, 2020
Workshop: RDCA-DAP 2020 Virtual Workshop
Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about:
– RDCA-DAP’s first year progress and development
– How RDCA-DAP will work to accelerate rare disease drug development
– How the platform works: improved ability to search and sort data
– Case studies on how sharing patient-level data accelerates understanding of rare diseases
– Ways to get involved and the benefits of engaging with RDCA-DAP
Monday, October 19, 11 a.m. – 3:30 p.m. ET. Register now.
September 18, 2020
Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis
Despite increasing numbers of drug targets and technologies, rare disease drug development is frequently slowed by the low numbers of patients and the lack of comprehensive quantitative characterization of diseases. Tucson’s Critical Path Institute (C-Path), along with the National Organization of Rare Disorders and the FDA, have developed an integrated database and analytics hub called the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) to help accelerate clinical development, make it less expensive, and encourage new companies to develop treatments for rare diseases.
Jane Larkindale, D.Phil. Critical Path Institute, Executive Director Rare Disease Cures Accelerator-Data and Analytics Platform; Duchenne Regulatory Science Consortium
Vanessa Boulanger, MSc, National Organization for Rare Disorders, Director of Research Programs
Michelle Campbell, PhD, U.S. Food and Drug Administration, Sr. Clinical Analyst for Stakeholder Engagement and Clinical Outcomes, Division of Neurology Products
Part of Arizona Bioscience Week Educational Events | Register for AZBW 2020